We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+2.35%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$24.3B
AUM Growth
-$663M
(-2.7%)
Cap. Flow
-$1.37B
Cap. Flow
% of AUM
-5.66%
Top 10 Holdings %
Top 10 Hldgs %
15.29%
Holding
1,567
New
158
Increased
553
Reduced
532
Closed
145
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$130M |
| 2 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$126M |
| 3 |
MetLife
MET
|
+$107M |
| 4 |
General Mills
GIS
|
+$92.4M |
| 5 |
Parker-Hannifin
PH
|
+$71.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$199M |
| 2 |
RTN
Raytheon Company
RTN
|
+$151M |
| 3 |
Delta Air Lines
DAL
|
+$148M |
| 4 |
Norfolk Southern
NSC
|
+$145M |
| 5 |
Boston Scientific
BSX
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.77% |
| 2 | Financials | 14.55% |
| 3 | Technology | 14.11% |
| 4 | Consumer Discretionary | 8.63% |
| 5 | Industrials | 8.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MACK
576
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $5.26M | 0.02% |
56,279
+35,221
| +167% | +$3M |
|
577
Cabot Corp
CBT
$4.09B
| $5.22M | 0.02% |
115,900
-3,600
| -3% | -$159K |
|
|
HTWR
578
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $5.21M | 0.02% |
59,311
-2,544
| -4% | -$216K |
|
579
Ball Corp
BALL
$16.1B
| $5.18M | 0.02% |
146,800
+13,000
| +10% | +$450K |
|
580
Brinker International
EAT
$8.5B
| $5.18M | 0.02% |
84,100
+22,600
| +37% | +$1.36M |
|
|
EIGR
581
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $5.18M | 0.02% |
607
+158
| +35% | +$1.38M |
|
|
BIG
582
DELISTED
Big Lots, Inc.
BIG
| $5.17M | 0.02% |
107,700
+21,800
| +25% | +$1.03M |
|
583
Hyatt Hotels
H
$15.1B
| $5.17M | 0.02% |
87,260
+7,630
| +10% | +$446K |
|
584
Vanguard FTSE Emerging Markets ETF
VWO
$125B
| $5.14M | 0.02% |
125,700
+71,800
| +133% | +$2.92M |
|
585
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$18.8B
| $5.11M | 0.02% |
+47,300
| New | +$4.93M |
|
|
HAWK
586
DELISTED
Blackhawk Network Holdings, Inc. Common Stock
HAWK
| $5.11M | 0.02% |
142,817
+86,143
| +152% | +$3.06M |
|
|
MBT
587
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
| $5.08M | 0.02% |
502,485
+276,818
| +123% | +$2.5M |
|
|
POT
588
DELISTED
Potash Corp Of Saskatchewan
POT
| $5.07M | 0.02% |
157,400
-45,400
| -22% | -$1.6M |
|
589
Northern Trust
NTRS
$32.7B
| $5.04M | 0.02% |
72,300
+16,100
| +29% | +$1.1M |
|
590
Cheniere Energy
LNG
$56B
| $4.93M | 0.02% |
63,720
-14,619
| -19% | -$1.09M |
|
591
Bio-Rad Laboratories Class A
BIO
$10.1B
| $4.91M | 0.02% |
36,300
+6,600
| +22% | +$818K |
|
|
AUY
592
DELISTED
Yamana Gold, Inc.
AUY
| $4.89M | 0.02% |
1,365,180
+109,391
| +9% | +$443K |
|
593
NOV
NOV
$7.48B
| $4.82M | 0.02% |
96,400
-29,314
| -23% | -$1.59M |
|
|
CIT
594
DELISTED
CIT Group Inc.
CIT
| $4.76M | 0.02% |
105,500
-60,181
| -36% | -$2.73M |
|
|
SRC
595
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $4.72M | 0.02% |
87,104
-2,921
| -3% | -$162K |
|
596
Microchip Technology
MCHP
$38.8B
| $4.69M | 0.02% |
192,000
| – | – |
|
|
MGLN
597
DELISTED
Magellan Health Services, Inc.
MGLN
| $4.68M | 0.02% |
66,052
+364
| +0.6% | +$22.9K |
|
|
SVU
598
DELISTED
SUPERVALU Inc.
SVU
| $4.67M | 0.02% |
57,420
+45,363
| +376% | +$3.25M |
|
|
PPLI
599
People Inc
PPLI
$2.85B
| $4.67M | 0.02% |
387,376
-413,327
| -52% | -$4.78M |
|
|
SPTN
600
DELISTED
SpartanNash
SPTN
| $4.66M | 0.02% |
147,483
+21,800
| +17% | +$588K |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q1 2015 Portfolio in Review
As of Q1 2015, Axa held 1,567 positions worth $24.3B, down 2.7% from $24.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Axa withdrew a net $1.37B in Q1 2015, closing 145 positions and reducing 532 holdings. Its most notable exit was Viatris, an estimated $55.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Financials and Technology.
Against the trend, Axa opened a new position in Nasdaq worth $42.1M.
- Axa's largest Q1 2015 buy was Nasdaq: 2,480,223 shares worth $42.1M.
- Axa added most to Johnson & Johnson in Q1 2015, an estimated $130M increase.
- Axa's biggest Q1 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $199M.
- Axa fully exited Viatris in Q1 2015, selling an estimated $55.8M.
- Axa's ten largest holdings make up 15% of its $24.3B portfolio in Q1 2015.
- Axa opened 158 new positions and closed 145 in Q1 2015.
- Axa's portfolio value fell 2.7% quarter-over-quarter to $24.3B.
Based on Axa's 13F filing for Q1 2015, filed 13 May 2015.